Well Referenced

Tag: female sexual health

Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials

Two phase 3 randomized, double-blind, placebo-controlled trials evaluated the safety and efficacy of bremelanotide, a melanocortin receptor agonist, for treating hypoactive sexual desire disorder (HSDD) in premenopausal women. The trials included 1,267 participants, primarily white and U.S.-based, who received a 1.75 mg subcutaneous injection as needed before sexual activity. Bremelanotide

Read More »
June 26, 2025 No Comments

Dehydroepiandrosterone therapy as female androgen replacement

The article titled “Dehydroepiandrosterone therapy as female androgen replacement” (Seminars in Reproductive Medicine, 2006, PMID: 16633983) reviews the role of dehydroepiandrosterone (DHEA) supplementation as androgen replacement therapy in women, particularly focusing on menopausal and postmenopausal populations. It highlights potential improvements in sexual function, bone mineral density, mood, and overall well-being,

Read More »
June 26, 2025 No Comments

Role of testosterone in the treatment of hypoactive sexual desire disorder

This review examines the role of testosterone therapy in treating hypoactive sexual desire disorder (HSDD) in postmenopausal women, highlighting its potential to improve sexual desire, satisfaction, and frequency of satisfying sexual encounters. While some studies support its efficacy, results are not uniform across trials. Testosterone influences sexual desire by acting

Read More »
June 26, 2025 No Comments